🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/03/1979 | 1,77 | 1,80 | 1,77 | 1,78 | +0,57% | 1,68% | 996.019 |
| 08/03/1979 | 1,76 | 1,78 | 1,75 | 1,77 | +0,38% | 1,69% | 1.897.718 |
| 07/03/1979 | 1,74 | 1,77 | 1,74 | 1,76 | +1,34% | 1,91% | 1.486.483 |
| 06/03/1979 | 1,74 | 1,75 | 1,73 | 1,74 | +0,00% | 1,15% | 1.678.896 |
| 05/03/1979 | 1,71 | 1,74 | 1,71 | 1,74 | +1,35% | 1,35% | 1.067.702 |
| 02/03/1979 | 1,72 | 1,73 | 1,71 | 1,71 | -0,19% | 1,16% | 1.844.899 |
| 01/03/1979 | 1,73 | 1,73 | 1,71 | 1,72 | -0,77% | 0,96% | 1.026.202 |
| 28/02/1979 | 1,72 | 1,73 | 1,71 | 1,73 | +0,77% | 1,16% | 1.365.754 |
| 27/02/1979 | 1,73 | 1,73 | 1,72 | 1,72 | -0,96% | 0,58% | 1.856.218 |
| 26/02/1979 | 1,74 | 1,75 | 1,73 | 1,73 | -0,38% | 1,14% | 1.275.206 |
| 23/02/1979 | 1,73 | 1,76 | 1,73 | 1,74 | +0,57% | 1,53% | 1.999.584 |
| 22/02/1979 | 1,75 | 1,75 | 1,73 | 1,73 | -1,32% | 1,32% | 2.229.725 |
| 21/02/1979 | 1,76 | 1,78 | 1,75 | 1,75 | -0,56% | 1,32% | 1.909.037 |
| 20/02/1979 | 1,75 | 1,76 | 1,71 | 1,76 | +0,75% | 3,03% | 3.761.482 |
| 16/02/1979 | 1,78 | 1,78 | 1,75 | 1,75 | -2,04% | 1,86% | 1.501.574 |
| 15/02/1979 | 1,79 | 1,79 | 1,77 | 1,79 | -0,74% | 0,92% | 1.712.851 |
| 14/02/1979 | 1,80 | 1,81 | 1,79 | 1,80 | +0,19% | 1,29% | 1.346.890 |
| 13/02/1979 | 1,78 | 1,80 | 1,78 | 1,80 | +1,30% | 1,12% | 1.788.307 |
| 12/02/1979 | 1,77 | 1,77 | 1,76 | 1,77 | +0,00% | 0,75% | 2.456.093 |
| 09/02/1979 | 1,79 | 1,80 | 1,77 | 1,77 | -0,74% | 1,48% | 1.271.434 |
| 08/02/1979 | 1,77 | 1,80 | 1,77 | 1,79 | +1,13% | 1,69% | 2.622.096 |
| 07/02/1979 | 1,76 | 1,78 | 1,75 | 1,77 | +0,19% | 1,50% | 2.784.326 |
| 06/02/1979 | 1,76 | 1,78 | 1,76 | 1,76 | +0,00% | 1,50% | 1.550.621 |
| 05/02/1979 | 1,78 | 1,78 | 1,76 | 1,76 | -1,12% | 1,30% | 1.309.162 |
| 02/02/1979 | 1,80 | 1,80 | 1,78 | 1,78 | -0,92% | 1,29% | 1.527.984 |
| 01/02/1979 | 1,80 | 1,81 | 1,78 | 1,80 | -0,18% | 1,47% | 5.051.779 |
| 31/01/1979 | 1,82 | 1,82 | 1,79 | 1,80 | -0,73% | 1,65% | 3.135.197 |
| 30/01/1979 | 1,82 | 1,86 | 1,81 | 1,82 | -0,37% | 2,73% | 3.433.248 |
| 29/01/1979 | 1,83 | 1,84 | 1,82 | 1,82 | -0,36% | 1,27% | 1.516.666 |
| 26/01/1979 | 1,83 | 1,84 | 1,80 | 1,83 | +0,18% | 1,99% | 3.010.694 |